Literature DB >> 12687453

Calcium-free hemodialysis for hypercalcemia of malignancy in a newborn.

Madhura Pradhan1, Mary B Leonard.   

Abstract

Hypercalcemia associated with malignancy is very rare in the newborn period. Severe hypercalcemia causes neurological and cardiological disturbances and can be life threatening. Calcium-free hemodialysis has not been reported for the treatment of malignancy associated hypercalcemia in neonates. We report a 5-day-old infant with severe hypercalcemia (serum calcium 22 mg/dl) secondary to a solid tumor in the pelvis. Aggressive pharmacological treatment with furosemide, pamidronate, and calcitonin failed to reduce the serum calcium adequately. Implementation of calcium-free hemodialysis resulted in a rapid reduction of the serum calcium from 22.6 mg/dl to 11.6 mg/dl. Hemodialysis was well tolerated with no hemodynamic complications. Continuous veno-venous hemodialysis was used to maintain normocalcemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12687453     DOI: 10.1007/s00467-003-1138-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

Review 1.  Recent advances in pathophysiology and treatment of hypercalcemia of malignancy.

Authors:  G R Mundy; A J Yates
Journal:  Am J Kidney Dis       Date:  1989-07       Impact factor: 8.860

2.  Role of dialysis in the treatment of severe hypercalcemia: report of two cases successfully treated with hemodialysis and review of the literature.

Authors:  C J Cardella; B L Birkin; A Rapoport
Journal:  Clin Nephrol       Date:  1979-12       Impact factor: 0.975

Review 3.  Hypercalcemia of the newborn: etiology, evaluation, and management.

Authors:  C Rodd; P Goodyer
Journal:  Pediatr Nephrol       Date:  1999-08       Impact factor: 3.714

4.  Leukaemia-associated hypercalcaemia in a 10-year-old boy: effectiveness of aminohydroxypropylidene biphosphonate.

Authors:  B R Boudailliez; B J Pautard; J L Sebert; O Kremp; C X Piussan
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

5.  Use of pamidronate in the management of acute cancer-related hypercalcemia in children.

Authors:  G Young; A Shende
Journal:  Med Pediatr Oncol       Date:  1998-02

Review 6.  Overview of cancer-related hypercalcemia: epidemiology and etiology.

Authors:  F M Muggia
Journal:  Semin Oncol       Date:  1990-04       Impact factor: 4.929

7.  Calcium free hemodialysis: an effective therapy in hypercalcemic crisis--report of 4 cases.

Authors:  W Kaiser; G Biesenbach; R Kramar; J Zazgornik
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

8.  Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia.

Authors:  C Camus; C Charasse; I Jouannic-Montier; P Seguin; Y L Tulzo; J Bouget; R Thomas
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

9.  Calcium-free hemodialysis for the management of hypercalcemia.

Authors:  W S Koo; D S Jeon; S J Ahn; Y S Kim; Y S Yoon; B K Bang
Journal:  Nephron       Date:  1996       Impact factor: 2.847

10.  Continuous arteriovenous hemofiltration--a new treatment in hypercalcemic crisis.

Authors:  H Schou; F Knudsen
Journal:  Blood Purif       Date:  1988       Impact factor: 2.614

View more
  3 in total

1.  Use of Calcitonin for Hypercalcemia in a Premature Neonate With Congenital Mesoblastic Nephroma.

Authors:  Malia S Kleespies; Pooja A Shah; Deborah S Bondi
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26

2.  Clinical pharmacology of furosemide in neonates: a review.

Authors:  Gian Maria Pacifici
Journal:  Pharmaceuticals (Basel)       Date:  2013-09-05

3.  Severe hypercalcemia as a form of acute lymphoblastic leukemia presentation in children.

Authors:  Andreia Luís Martins; Marta Moniz; Pedro Sampaio Nunes; Clara Abadesso; Helena Cristina Loureiro; Ximo Duarte; Helena Isabel Almeida
Journal:  Rev Bras Ter Intensiva       Date:  2015 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.